Since the relevant gene and protein expression of PLA2G7/PAF-AH were detected exclusively in the BRCA1 mutant cell line UWB1.289 (Figure 4), PAF-AH can be considered a new biomarker for BRCA1 mutant ovarian cancer, indicating good prognosis. The gene discussed is PLA2G7; the disease is ovarian carcinoma.